+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

E

Actively Recruiting

Researchers are evaluating the use of transcranial direct current stimulation tDCS to reduce suicidal thoughts in adults diagnosed with depression. This pilot study focuses on patients who have treatment-resistant depression and aims to assess the effectiveness of 15 sessions of tDCS delivered daily. The study is sponsored by Centre Hospitalier Henri Laborit and seeks to understand how this device-based therapy might help manage suicidal ideation. Participants will receive active tDCS treatment consisting of 15 daily sessions, each lasting 30 minutes with a 2 mA intensity. After completing the 15 stimulation sessions, patients will attend three follow-up visits scheduled on days 19, 49, and 79 to monitor changes and progress. The treatment phase and follow-up are designed to evaluate the effect of tDCS over time. During the study, participants will undergo initial screening to confirm eligibility and provide informed consent. Researchers will assess suicidal thoughts using the Scale for Suicide Ideation SSI at baseline and on day 19 after treatment. Additional assessments include depression severity with the Montgomery and Asberg Depression Rating Scale MADRS, implicit association tests for suicidal ideation, and quality of life surveys at multiple follow-up points. The study monitors safety and treatment response throughout the study period, which extends until December 2027.

Age: 18Years +All GendersPhase Not Applicable
2 locations
L

Actively Recruiting

The Dataids cohort is a large, ongoing observational study following over 30,000 HIV-infected patients receiving care at more than 15 HIV centers across France. The study aims to monitor clinical practice, changes in the course of HIV infection and related co-infections or co-morbidities, and assess factors influencing the clinical, immunological, and virological outcomes of HIV. It also evaluates the effectiveness of antiretroviral therapy ART and outcomes related to hepatitis C virus HCV treatment. Patients enrolled in the cohort are followed during routine outpatient visits, regardless of their CD4 cell count, HIV viral load, or ART status. Data collected annually include demographic information, immunological and virological measures, serological tests for hepatitis B, hepatitis C, and syphilis, as well as laboratory, therapeutic, and clinical data. This long-term study has been enrolling patients since 2010 and continues to collect data prospectively. Participants provide data through their scheduled clinic visits, and researchers track outcomes such as the proportion of patients with undetectable HIV viral load, ART usage patterns, HCV treatment uptake and success, CD4 cell counts, and incidence of HIV-related events. The main outcome measured is the proportion of treated patients with HIV plasma viral load below 50 copiesmL, averaged over six months. The study extends through 2030, with ongoing annual monitoring and data collection as part of routine care.

Age: 18Years +All Genders
39 locations